3997 studies found for:    "Sexually Transmitted Diseases, Viral"
Show Display Options
Rank Status Study
21 Recruiting Chemotherapy for Lung Cancer in HIV-positive Patients
Conditions: Non-small Cell Lung Cancer;   Hiv-positive
Intervention: Drug: Chemotherapy
22 Completed A Study of Patients Who Develop HIV Infection After Enrolling in HIV Vaccine Trials or HIV Vaccine Preparedness Trials
Condition: HIV Infections
Intervention: Other: Observation
23 Active, not recruiting Safety and Efficacy of Reduced Dose Efavirenz (EFV) With Standard Dose EFV Plus Two Nucleotide Reverse Transcriptase Inhibitors (N(t)RTI) in Antiretroviral-naïve HIV-infected Individuals.
Condition: HIV Infections
Intervention: Drug: Efavirenz
24 Completed
Has Results
A Study to Compare Brachial Artery Reactivity and Cardiovascular Risk of a Treatment Simplification by Darunavir/Ritonavir (DRV/r) 800/100 mg Versus a Triple Combination Therapy Containing DRV/r in HIV-1 Infected Patients
Condition: Human Immunodeficiency Virus 1
Interventions: Drug: Darunavir(DRV);   Drug: Ritonavir;   Drug: 2 nucleoside reverse transcriptase inhibitors (NRTIs)
25 Completed The Adult Antiretroviral Treatment and Resistance Study (Tshepo)
Conditions: AIDS;   HIV Infection
Interventions: Drug: (A) zidovudine, lamivudine and nevirapine;   Drug: (B) zidovudine, lamivudine and efavirenz;   Drug: (C) zidovudine, didanosine, and nevirapine;   Drug: (D) zidovudine, didanosine, and efavirenz;   Drug: (E) stavudine, lamivudine, and nevirapine;   Drug: (F) stavudine, lamivudine and efavirenz;   Procedure: Adherence Strategy Standard of Care (SOC);   Procedure: Adherence Strategy Community-Based DOT
26 Completed A Study of Anti-HIV Monoclonal Antibody KD-247
Condition: HIV Infections
Interventions: Drug: KD-247;   Drug: Physiological saline
27 Active, not recruiting Epidemiology and Pathogenesis of HIV-Associated Pulmonary Hypertension
Conditions: HIV Infection;   Pulmonary Hypertension;   Endothelial Function;   HIV Infections
Intervention:
28 Terminated Can Presumptive Anthelminthic Treatment Delay the Progression of HIV in ART-naïve Patients in Rural Africa?
Conditions: HIV Infections;   Helminthiasis
Intervention: Drug: Praziquantel, Ivermectin, Albendazole
29 Completed A Study of AZT Plus Human Interferon Alpha in the Treatment of AIDS-Related Kaposi's Sarcoma
Conditions: Sarcoma, Kaposi;   HIV Infections
Interventions: Drug: Interferon alfa-2a;   Drug: Zidovudine;   Drug: Interferon alfa-n1
30 Completed A Pilot Study of Fluconazole Plus Flucytosine for the Treatment of AIDS Patients With Acute Cryptococcal Meningitis.
Conditions: Meningitis, Cryptococcal;   HIV Infections
Interventions: Drug: Flucytosine;   Drug: Fluconazole
31 Not yet recruiting Structured Treatment Interruption (STI) in Acute/Primary HIV
Condition: HIV Infections
Intervention: Other: Gradual anti-HIV treatment interruption
32 Completed Study to Evaluate HIV Viremia and Persistence in Acutely HIV-Infected ARV Naïve Patients Treated With Darunavir/Ritonavir and Etravirine
Conditions: Acute HIV Infection;   HIV Infections
Intervention: Drug: Darunavir/Ritonavir and Etravirine
33 Terminated TMC114-C227: A Study to Evaluate the Effectiveness and Safety of TMC114 (Darunavir) With a Low Dose of Ritonavir as Monotherapy (no Other Anti-HIV Drugs Will be Given) in Patients Who Have Never Been Treated With Antiretrovirals (Anti-HIV Drugs) Previously
Condition: HIV Infections
Intervention: Drug: TMC114 (darunavir) / ritonavir
34 Completed GSK1349572 Relative Bioavailability Study
Condition: HIV Infections
Interventions: Drug: GSK1349572 formulation AP;   Drug: GSK1349572 formulation AW;   Drug: GSK1349572 formulation AX
35 Completed TBTC Study 23C: Pharmacokinetics of Intermittent Rifabutin and Isoniazid With Daily Efavirenz
Conditions: HIV Infections;   Tuberculosis
Interventions: Drug: Rifabutin;   Drug: Efavirenz
36 Completed A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox-gp160 MN (ALVAC vCP125, HIV-1 gp160 MN) in HIV-1 Uninfected Adult Volunteers
Condition: HIV Infections
Interventions: Biological: ALVAC-HIV gp160MN (vCP125);   Biological: ALVAC-RG Rabies Glycoprotein (vCP65);   Biological: rgp120/HIV-1 SF-2
37 Completed A Phase I Clinical Trial To Evaluate the Toxicity, Antiviral and Immunomodulatory Effects of a Range of Doses of Ampligen in HIV-Infected Subjects
Condition: HIV Infections
Intervention: Drug: Ampligen
38 Completed A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 (rCD4) in Patients With AIDS and AIDS-Related Complex
Condition: HIV Infections
Intervention: Drug: CD4 Antigens
39 Completed Safety of AMD070 When Administered Alone or Boosted With Low-Dose Ritonavir in HIV Uninfected Men
Condition: HIV Infections
Interventions: Drug: Ritonavir;   Drug: AMD070
40 Completed A Study of Physical and Metabolic Abnormalities in HIV Infected and Uninfected Children and Youth
Conditions: HIV Infections;   HIV-Associated Lipodystrophy Syndrome;   HIV Lipodystrophy Syndrome;   Lipodystrophy;   Dyslipidemia;   Osteoporosis;   Osteopenia
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years